Ignite Creation Date:
2024-05-06 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05267327
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-03-04
First Post:
2022-02-28
Brief Title:
A Prospective Post-Marketing Observational Safety Study of Verzenios Abemaciclib Among Breast Cancer Patients in China Verzenios Abemaciclib Among Breast
Sponsor:
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
104 Weeks
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
1500
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Other |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 83542 |
Who Masked List: